跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OLANZAPINE-TEVA FC TABLET 5MG - HSA Drug Approval Details
Approvals
/
HSA
/
OLANZAPINE-TEVA FC TABLET 5MG
Approved
THERAPEUTIC
OLANZAPINE-TEVA FC TABLET 5MG
Teva Pharmaceutical Works Private Limited Company (HUNGARY)
🇸🇬 Health Sciences Authority
Approval Date
Feb 27, 2026
Approval ID
e75ec0df47f1a6bd
Company
Teva Pharmaceutical Works Private Limited Company (HUNGARY)
Type
Therapeutic
Approval Details
Approval Id
e75ec0df47f1a6bd
Drug Name
OLANZAPINE-TEVA FC TABLET 5MG
Product Name
OLANZAPINE-TEVA FC TABLET 5MG
Approval Number
SIN17473P
Approval Date
2026-02-27
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 27, 2026
Approval ID
e75ec0df47f1a6bd
Type
Therapeutic
Back to HSA Approvals